“Over past two decades, MPM Capital has invested over $2 billion in the launch and growth of over 100 biotech companies and played a lead role building some of most notable companies in biotech including Pharmasset, Biomarin, Epizyme and Pacira. We have also witnessed the growth of digital health and have in invested in such vanguards as 23andMe. We believe that innovations leveraging digital technologies to improve the development of medicines and to directly impact patient care will flourish in the coming years. DigiTx Partners is an ideal vehicle to tap into this compelling arena and to contribute to its development.”
Founder and Managing Partner, MPM Capital
“Exploring unprecedented medical solutions by leveraging Astellas’ strengths in the innovative drug business and integrating these strengths with various medical and healthcare areas is one of the important initiatives of our “Creating Innovation” strategy as part of Astellas Strategic Plan. Through the investment activities of DigiTx Partners, we will explore the business opportunities in the growing field of digital health and extend our knowledge in the area. We look forward to supporting those companies with technologies that will deliver innovative solutions impacting patients’ healthcare and wellness.”
Kenji Yasukawa, Ph.D.
Senior Vice President and Chief Strategy Officer, Astellas
“In the digital health space, there is no shortage of innovative technologies and companies that would markedly improve healthcare and the effective delivery of this care to the community. DigiTx Partners aims to identify and foster those companies that will meaningfully contribute to this improvement. From day one, it will be able to leverage the considerable resources of both Astellas and MPM Capital to execute on this goal.”
David J. Kim
CEO, DigiTx Partners
Digital Health holds tremendous promise to improve healthcare - both the implementation and the experience. As just one example, until recently, the practice of medicine was a paper-based system with doctors writing notes in charts and patients noting their complaints on paper surveys on clipboards. But now, many patients interact with their providers electronically and have instantaneous access to their medical records and results of diagnostic tests. More broadly, application of technologies that are now commonplace in other business sectors e.g. on-line appointment booking are beginning to be applied in healthcare. On a different axis, we are at the early stages of capturing and analyzing vast amount of healthcare data on individuals and populations, ranging from how many steps walked in a day to phenotypic characteristics of genetic mutations, that will influence how people make decisions about their care in the future.
At DigiTx Partners,we believe that the pace of change in healthcare will only accelerate in the coming years. We believe that there are many smart people with great insights and drive who are developing innovative technologies and solutions. We look forward to supporting innovative companies that will make a difference in our healthcare ecosystem, from companies that will change how patients navigate the healthcare system, that will integrate the disparate elements that comprise both diagnosis and treatment, that will speed the development of more effective drugs and that will enhance and enable efficient and accurate physician-patient interaction. DigiTx Partners looks forward to investing in those digital health companies that strive to keep all of us in better health.
For more information, email firstname.lastname@example.org.
David J. Kim, MD
CEO, DigiTx Partners